Seneca Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SVV-001 / Seneca Therap
NCT06889493: SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

Recruiting
1
36
US
Seneca Valley Virus-001 (SVV-001), Nivolumab, Ipilimumab
Aman Chauhan, MD, Seneca Therapeutics
Neuroendocrine Carcinoma, Neuroendocrine Tumors
06/30
06/30
SVV-012 / Seneca Therap
No trials found
SVV-024 / Seneca Therap
No trials found
SVV-037 / Seneca Therap
No trials found
SVV-044 / Seneca Therap
No trials found
SVV-058 / Seneca Therap
No trials found
SVV- 069 / Seneca Therap
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SVV-001 / Seneca Therap
NCT06889493: SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

Recruiting
1
36
US
Seneca Valley Virus-001 (SVV-001), Nivolumab, Ipilimumab
Aman Chauhan, MD, Seneca Therapeutics
Neuroendocrine Carcinoma, Neuroendocrine Tumors
06/30
06/30
SVV-012 / Seneca Therap
No trials found
SVV-024 / Seneca Therap
No trials found
SVV-037 / Seneca Therap
No trials found
SVV-044 / Seneca Therap
No trials found
SVV-058 / Seneca Therap
No trials found
SVV- 069 / Seneca Therap
No trials found

Download Options